
The Swiss SMI advanced 0.39% to 12,037.22, aligning with broader European market gains, as investor sentiment improved following news of deferred US trade tariffs. Notable outperformers included Kuehne + Nagel (+2.5%) and UBS Group (+2%), with Belimo Holding also seeing a 2.3% rise on robust net sales. Meanwhile, Swiss producer and import prices declined 0.9% year-on-year in December, marking the slowest decrease in 14 months, suggesting a moderation of deflationary pressures despite an average 1.7% annual fall in 2024 driven by pharmaceutical products.
The Swiss market, as measured by the SMI index, advanced 0.39% to close at 12,037.22, driven by broad European market optimism following the deferral of U.S. trade tariffs. The rally was supported by strong individual stock performance, with Kuehne + Nagel gaining nearly 2.5% and UBS Group adding 2.0%. Notably, Belimo Holding rose 2.3% on fundamental news, reporting a year-over-year increase in net sales to 943.9 million francs from 858.8 million francs. However, the gains were not universal, as major insurers like Zurich Insurance Group (-1.67%) and Swiss Life Holding (-0.5%) underperformed. On the macroeconomic front, while producer and import prices continued to fall in December, the 0.9% year-on-year decline marked the slowest pace in fourteen months, suggesting a moderation of deflationary pressures. This moderation follows a 1.5% decline in November and contrasts with the 1.7% average annual price decrease in 2024, which was heavily influenced by lower pharmaceutical product costs.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately positive
Sentiment Score
0.50
Ticker Sentiment